QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
NYSE:NHI

National Health Investors (NHI) Stock Price, News & Analysis

$62.83
+1.01 (+1.63%)
(As of 04:10 PM ET)
Today's Range
$61.98
$62.93
50-Day Range
$51.61
$62.05
52-Week Range
$47.54
$62.93
Volume
199,570 shs
Average Volume
175,978 shs
Market Capitalization
$2.73 billion
P/E Ratio
20.07
Dividend Yield
5.73%
Price Target
$59.22

National Health Investors MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
5.5% Downside
$59.22 Price Target
Short Interest
Bearish
2.40% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.59
Upright™ Environmental Score
News Sentiment
0.71mentions of National Health Investors in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$586,900 Bought Last Quarter
Proj. Earnings Growth
4.60%
From $4.35 to $4.55 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.99 out of 5 stars

Finance Sector

264th out of 850 stocks

Real Estate Investment Trusts Industry

51st out of 179 stocks

NHI stock logo

About National Health Investors Stock (NYSE:NHI)

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

NHI Stock Price History

NHI Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Canadian Diplomats Dispute Havana Study Findings
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
National Health Investors Inc
Q4 2023 National Health Investors Inc Earnings Call
National Health Investors (NHI) Q4 FFO Top Estimates
See More Headlines
Receive NHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/09/2022
Ex-Dividend for 1/26 Dividend
12/28/2023
Dividend Payable
1/26/2024
Ex-Dividend for 5/3 Dividend
3/27/2024
Today
3/28/2024
Dividend Payable
5/03/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
CUSIP
63633D10
Employees
26
Year Founded
1991

Price Target and Rating

Average Stock Price Target
$59.22
High Stock Price Target
$69.00
Low Stock Price Target
$50.00
Potential Upside/Downside
-4.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
8 Analysts

Profitability

Net Income
$135.65 million
Pretax Margin
42.02%

Debt

Sales & Book Value

Annual Sales
$319.83 million
Cash Flow
$4.91 per share
Book Value
$29.13 per share

Miscellaneous

Free Float
40,258,000
Market Cap
$2.68 billion
Optionable
Optionable
Beta
0.94

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. D. Eric Mendelsohn (Age 62)
    President, CEO & Director
    Comp: $1.21M
  • Mr. John L. Spaid (Age 64)
    Executive VP of Finance, CFO & Treasurer
    Comp: $699.15k
  • Mr. Kevin Carlton Pascoe (Age 43)
    Executive VP & Chief Investment Officer
    Comp: $456.86k
  • Mr. David Louis Travis (Age 49)
    Senior VP & Chief Accounting Officer
    Comp: $484.15k
  • Ms. Kristin Sallee Gaines (Age 52)
    Senior VP & Chief Transaction Officer
    Comp: $564.94k
  • Mr. Dana Rolfson Hambly
    Director of Investor Relations
  • Mr. Kimberly Ouimet
    Director of Corporate Compliance & Human Resources
  • Ms. Michelle R. Kelly
    Senior Vice President of Investments
  • Susan V. Sidwell
    Corporate Secretary
  • Ms. Colleen Schaller
    Real Estate Transaction Manager

NHI Stock Analysis - Frequently Asked Questions

Should I buy or sell National Health Investors stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last twelve months. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NHI shares.
View NHI analyst ratings
or view top-rated stocks.

What is National Health Investors' stock price target for 2024?

8 analysts have issued 1 year target prices for National Health Investors' shares. Their NHI share price targets range from $50.00 to $69.00. On average, they expect the company's stock price to reach $59.22 in the next twelve months. This suggests that the stock has a possible downside of 5.5%.
View analysts price targets for NHI
or view top-rated stocks among Wall Street analysts.

How have NHI shares performed in 2024?

National Health Investors' stock was trading at $55.85 at the beginning of 2024. Since then, NHI stock has increased by 12.2% and is now trading at $62.66.
View the best growth stocks for 2024 here
.

Are investors shorting National Health Investors?

National Health Investors saw a increase in short interest in February. As of February 29th, there was short interest totaling 930,000 shares, an increase of 24.0% from the February 14th total of 749,800 shares. Based on an average daily volume of 179,500 shares, the days-to-cover ratio is currently 5.2 days. Currently, 2.3% of the shares of the stock are short sold.
View National Health Investors' Short Interest
.

When is National Health Investors' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our NHI earnings forecast
.

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) announced its quarterly earnings results on Monday, May, 9th. The real estate investment trust reported $0.18 EPS for the quarter, missing the consensus estimate of $0.63 by $0.45. The real estate investment trust earned $71.33 million during the quarter, compared to the consensus estimate of $73.06 million. National Health Investors had a trailing twelve-month return on equity of 10.65% and a net margin of 42.40%. The firm's revenue for the quarter was down 11.8% on a year-over-year basis. During the same period last year, the firm earned $1.24 earnings per share.

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors announced a quarterly dividend on Tuesday, February 20th. Shareholders of record on Thursday, March 28th will be paid a dividend of $0.90 per share on Friday, May 3rd. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.75%. The ex-dividend date is Wednesday, March 27th.
Read our dividend analysis for NHI
.

Is National Health Investors a good dividend stock?

National Health Investors (NYSE:NHI) pays an annual dividend of $3.60 per share and currently has a dividend yield of 5.85%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 115.02%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, NHI will have a dividend payout ratio of 79.12% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for NHI.

What guidance has National Health Investors issued on next quarter's earnings?

National Health Investors updated its FY 2024 earnings guidance on Tuesday, February, 20th. The company provided EPS guidance of 4.310-4.370 for the period, compared to the consensus EPS estimate of 4.330. The company issued revenue guidance of -.

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (14.16%), Vanguard Group Inc. (14.16%), Principal Financial Group Inc. (4.31%), Charles Schwab Investment Management Inc. (1.63%), Dimensional Fund Advisors LP (1.39%) and Northern Trust Corp (1.29%). Insiders that own company stock include Charlotte A Swafford, James R Jobe, Robert G Adams and Robert T Webb.
View institutional ownership trends
.

How do I buy shares of National Health Investors?

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NHI) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners